“…Pro-inflammatory cytokines within this group, such as IL-2, IL-6, IL-15, IL-21, IL-23, IL-17 and IL-18, have been demonstrated to be detrimental in mice models of IBD [93,97,110,111,112,113,114,115,116,117,118]. While anti-inflammatory cytokines within this group, such as IFNα/β, IL-10, IL-11 and IL-22, were shown to be beneficial in animal models of IBD, their administration did not show any significant beneficial effects in patients with IBD [119,120,121,122,123,124,125,126].…”